Search Results 171-180 of 17396 for hba1c

  1. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

    HbA1c =< 7%. Women must not be pregnant or breast-feeding; all females of childbearing potential must have a blood test or urine study within 7 days of ...

  2. Fuchs Clinical Trials - Mayo Clinic Research

    ... (HbA1c), and skin advanced glycation endproducts (AGE) and ... . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo Clinic · Employees ...

  3. Ravulizumab in Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    * Uncontrolled diabetes mellitus with glycosylated hemoglobin (HbA1c) \> 8.5%. * Clinically active Henoch-Schonlein purpura (IgA vasculitis) requiring ...

  4. Study to Evaluate the Effects of Vitamin B3 Derivative on Bone, Skeletal, Muscle and Metabolic Functions in Aging - Mayo Clinic

    Poorly controlled Diabetes Mellitus (HbA1c>8). Clinical History Exclusion Criteria: Confirmed diagnosis of Diabetes Mellitus in use of insulin. Subjects ...

  5. Epicardial Delivery Of XC001 Gene Therapy To Promote Angiogenesis In CAD Patients Undergoing Treatment With CABG - Mayo Clinic

    Diabetic individuals with glycosylated hemoglobin (HbA1c) \> 9.5% or with active proliferative diabetic retinopathy. 8\. A history or evidence of human ...

  6. A Study to Evaluate the Effectiveness and Safety of Brolucizumab vs. Aflibercept in Patients with Visual Impairment Due to Diabetic Macular Edema - Mayo Clinic

    Patients with type 1 or type 2 diabetes mellitus (DM) and Hemoglobin A1c (HbA1c) ≤ 12% at screening. Study eye: Visual impairment due to DME with: Best ...

  7. A Trial Investigating the Safety, Tolerability and Effectiveness of TransCon PTH Administered Daily in Adults With Hypoparathyroidism - Mayo Clinic

    type 1 diabetes mellitus or poorly controlled type 2 diabetes mellitus (HbA1C > 9%;; documented HbA1C result drawn within 12 weeks prior to Screening is ...

  8. Feasibility of Autologous Adipose-derived Stromal Cells from Stromal Vascular Fraction (SVF) to Treat Adults with Pressure Ulcers or Diabetic Foot Ulcers - Mayo Clinic

    HbA1c < 9. The ability of subjects to give appropriate consent or have an appropriate representative available to do so. The ability of subjects to return ...

  9. Statins for the Treatment of NASH - Mayo Clinic

    HbA1C > 9.0 %; 2. Neutrophil count < 1.0 x 10^9 / L; 3. Platelets < 100 10^9 / L; 4. Hemoglobin < 10 g/dl; 5. Albumin < 3.5 g; 6. Prolonged international ...

  10. AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH - Mayo Clinic

    HbA1c > 9% at Screening. Serum albumin < 3.5 g/dL at Screening. Estimated glomerular filtration rate (eGFR) < 50 mL/min/1.73 m^2 according to the ...